Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,425.00    0.00 (0.00%)
Bid:
5,400.00
Ask:
5,600.00
Spread: 200.00 (3.704%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Director Changes

17 Jul 2023 07:00

RNS Number : 1447G
Camellia PLC
17 July 2023
 

17th July 2023

 

Camellia Plc

(the "Company")

 

Director changes

 

Camellia Plc is pleased to announce the appointment of Byron Coombs as a director and Chief Executive Officer with effect from 25th September 2023.

 

Byron has extensive experience in the financial and investment management sectors and served as Chief Executive Officer of the Group's private bank, Duncan Lawrie, from 2014 until its sale in 2017, since when Byron has been employed by the Group as Investment Director. Byron is also a Non-executive Director of Julius Baer International Limited, from which position he will resign on 31st December 2023. He has previous non-executive and executive experience at Deutsche Bank UK, RBS Wealth Management, Citibank Private Bank, and Merrill Lynch Debt Markets. Byron's appointment follows an extensive candidate search.

 

Camellia's Chairman, Malcolm Perkins, who has also acted as Interim Chief Executive Officer since 1st July 2022, will continue as Interim Chief Executive until Byron Coombs' appointment in September. Malcolm will retire on 30th November 2023 following 51 years' service in the Group. Malcolm has provided outstanding leadership throughout the years; the Company thanks him for his loyalty, contribution and commitment, and wishes him all the very best in his retirement.

 

Simon Turner, currently a Non-executive Director of the Company, will become Non-executive Chairman upon the retirement of Malcolm Perkins. Simon will resign from his position as director of the Camellia Private Trust Company (the trustee of The Camellia Foundation (Bermuda)) and director of Camellia Holding AG, he will remain a trustee of the UK charity primarily funded by The Camellia Foundation and as a nominee of The Camellia Foundation on the Camellia Board. 

 

Stephen Buckland, a nominee of The Camellia Foundation on the Camellia Board, has been appointed a director of the Camellia Private Trust Company (the trustee of The Camellia Foundation (Bermuda)) and director of Camellia Holding AG.

 

The Board will also in due course appoint an additional independent Non-executive Director to increase the number to three, one of whom will be appointed as Senior Independent Director.

 

 

Additional Information

 

In accordance with the AIM Rules, the following information required to be disclosed in relation to the director is set out below. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules.

 

Full name:

Kenneth Byron Coombs (known as "Byron Coombs")

Age:

63

Current beneficial shareholding in the Company:

None

Current directorships:

Julius Baer International Limited

Previous directorships within the last 5 years:

FINHUMF

 

 

 

 

Enquiries

Camellia Plc 01622 746655

Malcolm Perkins, Chairman & Interim CEO

Amarpal Takk, Group General Counsel & Company Secretary

 

Panmure Gordon 020 7886 2500 

Nominated Adviser and Broker 

Emma Earl 

Rupert Dearden

Maitland/AMO 07785 292617

PR 

William Clutterbuck

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUQUMUPWGUQ
Date   Source Headline
7th Jun 201911:00 amRNSResult of AGM
6th Jun 201911:30 amRNSAGM Trading Statement
15th Apr 201912:13 pmRNSAnnual Report and Notice of AGM
11th Apr 20197:00 amRNSFinal Results
21st Mar 20194:40 pmRNSSecond Price Monitoring Extn
21st Mar 20194:35 pmRNSPrice Monitoring Extension
4th Dec 20187:00 amRNSTrading update
23rd Oct 20187:00 amRNSTrading Update
29th Aug 201811:40 amRNSInterim Report 2018
24th Aug 20187:00 amRNSHalf-year Report
8th Jun 201812:20 pmRNSResult of AGM
7th Jun 201811:30 amRNSAGM Trading Statement
25th Apr 20184:00 pmRNSAnnual Report and Notice of AGM
20th Apr 20181:57 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSFinal Results
21st Mar 20187:00 amRNSNotice of Results
22nd Dec 20179:42 amRNSDirectorate Change
6th Dec 201712:28 pmRNSTrading Statement
14th Nov 20173:00 pmRNSHolding(s) in Company
29th Aug 20173:20 pmRNSInterim report 2017
25th Aug 20177:00 amRNSHalf-year Report
2nd Jun 20171:13 pmRNSResult of AGM
1st Jun 201711:30 amRNSAGM Statement
11th May 20177:00 amRNSUpdate on Duncan Lawrie
2nd May 20172:05 pmRNSAnnual Financial Report
27th Apr 20177:00 amRNSFinal Results
21st Apr 20175:03 pmRNSUpdate on Duncan Lawrie
19th Dec 20167:00 amRNSUpdate on Duncan Lawrie
22nd Nov 20165:24 pmRNSHolding(s) in Company
30th Aug 20164:52 pmRNSHalf-year Report
25th Aug 201611:33 amRNSInterim Dividend 2016 - Record Date
25th Aug 20167:00 amRNSHalf-year Report
3rd Jun 20161:06 pmRNSResult of AGM
2nd Jun 201612:15 pmRNSAGM Statement
4th May 20161:12 pmRNSHolding(s) in Company
3rd May 20162:34 pmRNSAnnual Report and Notice of Annual General Meeting
29th Apr 20164:03 pmRNSDirector/PDMR Shareholding
28th Apr 20167:00 amRNSFinal Results
2nd Feb 20167:00 amRNSTrading Statement
12th Nov 201510:06 amRNSDirector/PDMR Shareholding
9th Nov 20157:00 amRNSSale of Loddon Engineering Limited
14th Sep 20152:08 pmRNSHalf Yearly Report
27th Aug 20157:00 amRNSHalf Yearly Report
27th Jul 20157:00 amRNSChange of Adviser
2nd Jul 20152:09 pmRNSBoard changes
5th Jun 201512:29 pmRNSResult of AGM
4th Jun 201511:30 amRNSAGM Statement
28th Apr 20153:45 pmRNSReport and Accounts
23rd Apr 20157:00 amRNSFinal Results
7th Apr 20152:43 pmRNSAKD Engineering Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.